Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Puma Biotechnology, Is It The Next CYNK ? New Investors May Be In Big Trouble Soon!

|Includes:Puma Biotechnology, Inc. (PBYI)

So everyone knows the news, PBYI is up 300%. I am going to share a few points based on my research on the company; no in-depth analysis here, just a few points for you to consider.

  • The company has the market cap of 7.2B and no revenue

  • A similar move in CYNK, stock jumped from only a few cents to $20 per share, the company then got halted by SEC and serious losses are expected. Puma is nowhere near a buy at these prices.

  • The 2018 revenue is expected to be 500M if everything goes right according to the CEO! (Trust me, not everything goes right within a business.)

  • Pfizer backed out from funding this drug, I am dying to know why? did they know something?!

  • The side effects of company's cancer drug is very unknown, take a look at what happened to Dara Biosciences with a similar pipeline.

  • The company has a history of giving mixed news, take a look at their history of PR and how the stock went from $140 a share to $60 just a few months ago.

  • No potential bidder at these prices, specially when we take to account the premium bid, the valuation would arrive at north of 10B which is simply unrealistic.

  • Companies like DARA, ARIA and ONTY are working on similar drugs and there stock prices are in fraction of what we see in PBYI.

  • To simplify, the stock price is on cocaine right now so I have no target for the coming weeks.

Additional disclosure: Information provided in this article is for informational purposes only and should not be regarded as investment advice or a recommendation regarding any particular security or course of action. This information is the writer's personal opinion about the companies mentioned in the article. Investors should conduct their own due diligence and consult with a registered financial adviser before making any investment decision.

Stocks: PBYI